| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.0088 | 0.9 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |